Company type | subsidiary of Merck KGaA |
---|---|
Nasdaq: SIAL | |
Industry | chemistry and biotechnology |
Founded | August 1975 |
Headquarters | Burlington, Massachusetts, United States[2] |
Key people | Matthias Heinzel (Life Science CEO) |
Products | life science technologies and specialty chemicals |
Revenue | EUR€ 6.86 billion (2020)[3] |
Number of employees | more than 20,000 |
Parent | Merck KGaA (100%)[4] |
Website | www |
Sigma-Aldrich (formally MilliporeSigma)[5][6] is an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group
Sigma-Aldrich was created in 1975 by the merger of Sigma Chemical Company and Aldrich Chemical Company. It grew through various acquisitions until it had over 9,600 employees and was listed on the Fortune 1000. The company has two United States headquarters, in St. Louis and Burlington, MA and has operations in approximately 40 countries.[7]
In 2015, the multinational chemical conglomerate Merck Group acquired Sigma-Aldrich for $17 billion.[8] The company is currently a part of Merck's life science business and in combination with Merck's earlier acquired Millipore, operates as MilliporeSigma.[5][6] It is headquartered in Burlington, Massachusetts, United States.[2]